Related Experiment Videos
Detection of Bacterial Contamination in Nanoparticle Formulations by Agar Plate Test
Timothy M Potter1, Barry W Neun1, Anna N Ilinskaya1
1Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, P.O. Box B, Frederick, MD, 21702, USA.
Abstract:
Bacterial contamination can confound the results of in vitro and in vivo preclinical tests. This protocol describes a procedure for detection of microbial contamination in nanotechnology-based formulations. Nanoparticle samples and controls are spread on the surface of agar and growth of bacterial colonies is monitored after 72 h of incubation. The intended purpose of this assay is to avoid introduction of microbial contamination into in vitro cell cultures and in vivo animal studies utilizing the test nanomaterial. This assay is not intended to certify the material as sterile.
Insights
This protocol detects microbial contamination in nanoparticle formulations. It prevents bacterial contamination in cell cultures and animal studies, ensuring reliable preclinical research results.
Area of Science:
- Nanotechnology
- Microbiology
- Preclinical Research
Background:
- Bacterial contamination can compromise the integrity of in vitro and in vivo preclinical studies.
- Nanotechnology-based formulations require rigorous testing to ensure they do not introduce microbial contaminants.
Purpose of the Study:
- To describe a reliable protocol for detecting microbial contamination in nanotechnology-based formulations.
- To prevent the introduction of microbial contamination into cell cultures and animal models during preclinical research.
Main Methods:
- Nanoparticle samples and controls are inoculated onto agar plates.
- Plates are incubated for 72 hours.
- Bacterial colony growth is monitored to detect contamination.
Main Results:
- The described method allows for the detection of microbial contamination in nanoparticle samples.
- The assay provides a means to identify contaminated batches before use in sensitive experimental settings.
Conclusions:
- This protocol offers a crucial step in quality control for nanotechnology-based formulations used in research.
- Implementing this assay helps ensure the validity and reproducibility of in vitro and in vivo preclinical data.